Cargando…
A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis
Berberine (BBR) has been reported that it has effects on inhibiting colorectal cancer (CRC). However, the mechanism of BBR on CRC also remains largely unknown. Herein, we investigated the therapeutic effects of BBR on CRC from the perspective of gut microbiota and metabolic alterations, which can pr...
Autores principales: | Chen, Haitao, Zhang, Fan, Zhang, Jin, Zhang, Xinjie, Guo, Yong, Yao, Qinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541814/ https://www.ncbi.nlm.nih.gov/pubmed/33072135 http://dx.doi.org/10.3389/fimmu.2020.588079 |
Ejemplares similares
-
Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota
por: Chen, Haitao, et al.
Publicado: (2022) -
Holistic view of heat acclimation alleviated intestinal lesion in mice with heat stroke based on microbiome‐metabolomics analysis
por: Huang, Xueyan, et al.
Publicado: (2023) -
The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves’ Disease Patients Through Regulating the Intestinal Microbiome
por: Han, Zhe, et al.
Publicado: (2022) -
Berberine and cinnamaldehyde together prevent lung carcinogenesis
por: Meng, Mingjing, et al.
Publicado: (2017) -
Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy
por: Zhou, Pei, et al.
Publicado: (2022)